Details of the Drug

General Information of Drug (ID: DM1DU20)

Drug Name

GSK3882347

Indication

Disease Entry	ICD 11	Status	REF
Urinary tract infection	GC08	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Bacterial Fimbrin D-mannose adhesin (Bact FimH)	TTTCRU2	FIMH_ECOLI	Antagonist	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT05138822) A Double-Blind, Double Dummy, Randomized, Phase 1b, Nitrofurantoin Controlled, Repeat Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Microbiological Response of GSK3882347 in Female Participants With Acute Uncomplicated Urinary Tract Infection. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of Fimbrion Therapeutics